Efforts to reduce the number of Australians dying from heart disease will be significantly boosted by a $150 million investment over the next decade.
Patients
Some interesting issues in the last couple of weeks of relevance to the MedTech industry.
Candice shares her story about living with congenital heart disease, and the role Edwards Life Sciences' HVT valves played in helping her live a...
Clinical trials initiated by medtech companies are on the rise in Australia.
Medtronic Diabetes' Hooman Hakami discusses the role of medtech in tackling diabetes, and the challenges confronting Australia's health system.
PulseLine was present at Medtronic this week to listen to over 120 healthcare leaders participate in the Medical Technology Association of Australia (MTAA) Value-Based...
Upgrade provides patients in Bowral and neighbourhood communities with access to the latest endoscopy platform.
The Senate Committee inquiry into pelvic mesh has released its report following its year-long deliberations. The Committee made 13 recommendations including mandatory reporting of...
If you are not directly involved in the Australian clinical trials space as part of your work, then you may not be aware that...
PulseLine visited Monash Heart to discuss the new technologies they're using, including Medtronic's Micra Transcatheter Pacing System, to improve the lives of Australians.